BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11817153)

  • 1. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary Statement for the 2001-2002 season: influenza vaccination of persons who experienced oculo-respiratory syndrome following previous influenza vaccination.
    National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2001 Nov; 27():1-7. PubMed ID: 11817153
    [No Abstract]   [Full Text] [Related]  

  • 2. Supplementary statement for the 2002-2003 influenza season: update on oculo-respiratory syndrome in association with influenza vaccination.
    Orr P
    Can Commun Dis Rep; 2002 Sep; 28(ACS-6):1. PubMed ID: 12219587
    [No Abstract]   [Full Text] [Related]  

  • 3. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2001 Jan; 27():1-3. PubMed ID: 11227823
    [No Abstract]   [Full Text] [Related]  

  • 4. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2003 Aug; 29():1-20. PubMed ID: 12961958
    [No Abstract]   [Full Text] [Related]  

  • 5. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?
    Skowronski DM; Strauss B; De Serres G; MacDonald D; Marion SA; Naus M; Patrick DM; Kendall P
    Clin Infect Dis; 2003 Mar; 36(6):705-13. PubMed ID: 12627354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ORS during the 2000-2001 influenza vaccination season.
    Choudhri Y; Walop W; Squires S; Tam T; King A; Skowronski D; Warrington R; Wood J
    Can Commun Dis Rep; 2002 Sep; 28(ACS-6):2-8. PubMed ID: 12219588
    [No Abstract]   [Full Text] [Related]  

  • 7. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season.
    Orr P;
    Can Commun Dis Rep; 2004 Jun; 30():1-32. PubMed ID: 15239483
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of revaccination of patients affected by the oculo-respiratory syndrome (ORS) following influenza vaccination.
    Grenier JL; Toth E; De Serres G; Ménard S; Roussel R; Tremblay M; Landry M; Robert Y; Skowronski DM
    Can Commun Dis Rep; 2004 Jan; 30(2):9-16. PubMed ID: 14964915
    [No Abstract]   [Full Text] [Related]  

  • 9. Oculo-respiratory syndrome following influenza vaccination: review of post-marketing surveillance through four influenza seasons in Canada.
    Can Commun Dis Rep; 2005 Nov; 31(21):217-25. PubMed ID: 16669126
    [No Abstract]   [Full Text] [Related]  

  • 10. Statement on influenza vaccination for the 2000-2001 season. An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2000 Jun; 26():1-16. PubMed ID: 10920540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations and incidence of oculo-respiratory syndrome following influenza vaccination--Quebec, 2000.
    Boulianne N; De Serres G; Duval B; Shadmani R; Rochette L
    Can Commun Dis Rep; 2001 May; 27(10):85-90. PubMed ID: 11396047
    [No Abstract]   [Full Text] [Related]  

  • 12. Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons.
    De Serres G; Toth E; Ménard S; Grenier JL; Roussel R; Tremblay M; Landry M; Robert Y; Rochette L; Skowronski DM
    Vaccine; 2005 May; 23(28):3726-32. PubMed ID: 15882534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected.
    Skowronski DM; De Serres G; Scheifele D; Russell ML; Warrington R; Davies HD; Dionne M; Duval B; Kellner J; MacDonald J
    Clin Infect Dis; 2003 Oct; 37(8):1059-66. PubMed ID: 14523770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Advisory Committee on Immunization (NACI) statement on influenza vaccination for the 1995-96 season.
    Can Commun Dis Rep; 1995 Jun; 21(12):105-13. PubMed ID: 7647747
    [No Abstract]   [Full Text] [Related]  

  • 15. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1998-1999 season.
    Can Commun Dis Rep; 1998 Jul; 24():1-12. PubMed ID: 10330776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1996-97 season.
    Can Commun Dis Rep; 1996 Jun; 22(12):89-97. PubMed ID: 8823972
    [No Abstract]   [Full Text] [Related]  

  • 17. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.
    Tam T; Langley J;
    Can Commun Dis Rep; 2004 Mar; 30():1-5. PubMed ID: 15035403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1993-94 season.
    Can Commun Dis Rep; 1993 May; 19(9):65-71. PubMed ID: 7686070
    [No Abstract]   [Full Text] [Related]  

  • 19. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1988-1989 season.
    Can Dis Wkly Rep; 1988 May; 14(19):77-82. PubMed ID: 3242878
    [No Abstract]   [Full Text] [Related]  

  • 20. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Jul; 33(ACS-7):1-38. PubMed ID: 17663034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.